Patrick A. McBrayer
Chief Executive Officer chez MIACH Orthopaedics, Inc.
Profil
Patrick A.
McBrayer is the founder of Transave, Inc. founded in 1997.
Currently, he is the President & Chief Executive Officer at MIACH Orthopaedics, Inc. since 2022.
Previously, he served as President & Chief Executive Officer at Exogen, Inc. and Osteotech, Inc. He was also the President, Chief Executive Officer & Director at AxioMed Spine Corp.
from 2006 to 2015.
Additionally, he served as the Chief Executive Officer & Director at Xylos Corp.
and President, Chief Executive Officer & Director at ACell, Inc. He was an Independent Director at Misonix, Inc. from 2014 to 2019.
He also worked as a Principal at Johnson & Johnson and a Trustee at The West Point Association of Graduates.
Mr. McBrayer graduated from the US Military Academy in 1974.
Postes actifs de Patrick A. McBrayer
| Sociétés | Poste | Début |
|---|---|---|
MIACH Orthopaedics, Inc.
 MIACH Orthopaedics, Inc. Medical SpecialtiesHealth Technology MIACH Orthopaedics, Inc. engages in developing of bio-engineered surgical implants for connective tissue repair. The company was founded by Martha Murray and is headquartered in Westborough, MA. | Chief Executive Officer | 07/09/2022 |
Anciens postes connus de Patrick A. McBrayer
| Sociétés | Poste | Fin |
|---|---|---|
| MISONIX, INC. | Director/Board Member | 01/09/2019 |
AxioMed Spine Corp.
 AxioMed Spine Corp. Pharmaceuticals: MajorHealth Technology AxioMed Spine Corp. was formed in 2001 to develop products with a goal of restoring spinal function to patients with degenerative spine disease; thus advancing the standard of care beyond fusion and first generation artificial discs. Since its inception, AxioMed has secured over $34M in private equity financing from prestigious venture capitalists. The company´s Freedom Lumbar Disc has been developed and clinical trials initiated. The company is headed by CEO, Patrick McBrayer, who joined AxioMed in early 2006. Mr. McBrayer along with founder and COO, James Kuras, lead an experienced management and development team with significant history and expertise in spinal implants, including early artificial disc development efforts. Company employment includes professionals with extensive spine and engineering experience. The team is augmented by a Medical Advisory Panel of surgeons from leading spine centers and universities. The company´s headquarters include product development and testing, clinical and regulatory affairs, and manufacturing. AxioMed will leverage its background in lumbar disc replacement with an ongoing development project for the cervical spine. | Chief Executive Officer | 01/01/2015 |
Transave, Inc.
 Transave, Inc. Pharmaceuticals: MajorHealth Technology Transave, Inc. is a biopharmaceutical company focused on developing innovative, inhaled pharmaceuticals for the site-specific treatment of serious lung diseases such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. They are committed to significantly improving the quality of life and healthcare of patients suffering from these life-threatening diseases. Its operating principles are centered on teamwork, openness, mutual respect, diversity of opinion, trust, accountability and innovative science. They are developing products based on Transave's proprietary liposomal technology designed specifically for lung delivery. Its focus is on reformulating off-patent, established drugs into unique liposomal technology - based inhaled pharmaceuticals for the localized, site-specific treatment of serious lung diseases. Transave's proprietary liposomal technology allows for the sustained release of a drug in the lung's microenvironment. By remaining in the lungs for a prolonged period and potentially minimizing systemic exposure, Transave's liposomal technology offers the potential for changing the product profile, improving delivery of the compound to the lung and enhancing the therapeutic index of established pharmaceuticals. | Founder | - |
| ACELL, INC. | Chief Executive Officer | - |
The West Point Association of Graduates
 The West Point Association of Graduates Miscellaneous Commercial ServicesCommercial Services The West Point Association of Graduates publishes memorial articles in memory of deceased graduates and former cadets. It offers support west point, read class notes, online gift shop and USAA credit card. The company was founded in 1869 and is headquartered in West Point, NY. | Director/Board Member | - |
Formation de Patrick A. McBrayer
| US Military Academy | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| Entreprise privées | 9 |
|---|---|
Exogen, Inc.
 Exogen, Inc. Medical SpecialtiesHealth Technology Exogen, Inc. designs, develops, manufactures and markets medical devices for treatment of musculoskeletal injury and disease. The company's products include sonic acclerated fracture healing system and mechanical stress devices. The products are sold in the United States, Europe and Japan. | Health Technology |
Osteotech, Inc.
 Osteotech, Inc. Medical SpecialtiesHealth Technology Osteotech, Inc. develops biologic products for orthopedic, spinal, trauma, neurosurgical, and maxillofacial surgeons for use in surgical procedures. It operates in five segments: demineralized bone matrix, hybrid/synthetic, traditional tissue, spinal allograft, and client services. The company processes, markets, and distributes Xenograft bone tissue products, which are used as bone graft substitutes. The company was founded in 1986 and is headquartered in Eatontown, NJ. | Health Technology |
Misonix, Inc.
 Misonix, Inc. Medical SpecialtiesHealth Technology Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. It operates through the following segments: Surgical and Wound. The Surgical segment consists of BoneScalpel and SonaStar products. The Wound segment consists of SonicOne, TheraSkin and Therion products. The company's ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. The company was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY. | Health Technology |
AxioMed Spine Corp.
AxioMed Spine Corp. Pharmaceuticals: MajorHealth Technology AxioMed Spine Corp. was formed in 2001 to develop products with a goal of restoring spinal function to patients with degenerative spine disease; thus advancing the standard of care beyond fusion and first generation artificial discs. Since its inception, AxioMed has secured over $34M in private equity financing from prestigious venture capitalists. The company´s Freedom Lumbar Disc has been developed and clinical trials initiated. The company is headed by CEO, Patrick McBrayer, who joined AxioMed in early 2006. Mr. McBrayer along with founder and COO, James Kuras, lead an experienced management and development team with significant history and expertise in spinal implants, including early artificial disc development efforts. Company employment includes professionals with extensive spine and engineering experience. The team is augmented by a Medical Advisory Panel of surgeons from leading spine centers and universities. The company´s headquarters include product development and testing, clinical and regulatory affairs, and manufacturing. AxioMed will leverage its background in lumbar disc replacement with an ongoing development project for the cervical spine. | Health Technology |
Xylos Corp.
 Xylos Corp. BiotechnologyHealth Technology Xylos Corp. provides biotechnology solutions. The firm operates as a medical device company that offers superior biomaterial solutions for the treatment, repair and replacement of human tissue. The company was founded by Gonzalo C. Serafica in 1996 and is headquartered in Newtown, PA. | Health Technology |
ACell, Inc.
 ACell, Inc. Pharmaceuticals: MajorHealth Technology ACell, Inc. develops and manufactures bioscaffold, extracellular matrix technology for medical and veterinary products. It offers the next generation of regenerative medicine through the development and commercialization of unique extracellular matrix devices to repair and remodel damaged tissues and organs in a broad range of surgical procedures. The firm's products include ABRA, Cytal Burn Matrix, Cytal Wound Matrix, Gentrix Surgical Matrix and MicroMatrix. It is a regenerative medicine company that focuses on the development, manufacturing and sale of products primarily used in acute care settings as part of the treatment and management of moderate to severe wounds and reinforcement of soft tissue surgical defects. The firm’s products utilizes proprietary porcine urinary bladder matrix platform technology, which is designed to enhance the body's ability to restore natural tissue and minimize scarring in the management of traumatic, surgical and chronic wounds, burns, hernias and other conditions requiring the reinforcement of soft tissue. The company was founded by Stephen Xavier Graham in June 1999 and is headquartered in Columbia, MD. | Health Technology |
Transave, Inc.
Transave, Inc. Pharmaceuticals: MajorHealth Technology Transave, Inc. is a biopharmaceutical company focused on developing innovative, inhaled pharmaceuticals for the site-specific treatment of serious lung diseases such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. They are committed to significantly improving the quality of life and healthcare of patients suffering from these life-threatening diseases. Its operating principles are centered on teamwork, openness, mutual respect, diversity of opinion, trust, accountability and innovative science. They are developing products based on Transave's proprietary liposomal technology designed specifically for lung delivery. Its focus is on reformulating off-patent, established drugs into unique liposomal technology - based inhaled pharmaceuticals for the localized, site-specific treatment of serious lung diseases. Transave's proprietary liposomal technology allows for the sustained release of a drug in the lung's microenvironment. By remaining in the lungs for a prolonged period and potentially minimizing systemic exposure, Transave's liposomal technology offers the potential for changing the product profile, improving delivery of the compound to the lung and enhancing the therapeutic index of established pharmaceuticals. | Health Technology |
The West Point Association of Graduates
The West Point Association of Graduates Miscellaneous Commercial ServicesCommercial Services The West Point Association of Graduates publishes memorial articles in memory of deceased graduates and former cadets. It offers support west point, read class notes, online gift shop and USAA credit card. The company was founded in 1869 and is headquartered in West Point, NY. | Commercial Services |
MIACH Orthopaedics, Inc.
MIACH Orthopaedics, Inc. Medical SpecialtiesHealth Technology MIACH Orthopaedics, Inc. engages in developing of bio-engineered surgical implants for connective tissue repair. The company was founded by Martha Murray and is headquartered in Westborough, MA. | Health Technology |
